Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer.

Jennifer Haynes, Trevor D McKee, Andrew Haller, Yadong Wang, Cherry Leung, Deena Gendoo, Evelyne Lima-Fernandes, Antonija Kreso, Robin Wolman, Eva Szentgyorgyi, Douglass C Vines, Benjamin Haibe-Kains, Bradly G Wouters, Ur Metser, David A Jaffray, Myles Smith, Catherine A O'Brien

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer.'. Together they form a unique fingerprint.

Medicine & Life Sciences